MSL
GILD icon

Mackay Shields LLC’s Gilead Sciences GILD Stock Holding History

Mackay Shields LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-181,555
Closed -$10.8M – 430
2022
Q1 		$10.8M Sell
181,555
-7,090
-4% -$453K 0.09% 212
2021
Q4 		$13.7M Sell
188,645
-4,443
-2% -$306K 0.11% 194
2021
Q3 		$13.5M Sell
193,088
-5,401
-3% -$379K 0.13% 180
2021
Q2 		$13.7M Sell
198,489
-110,524
-36% -$7.38M 0.13% 178
2021
Q1 		$20M Sell
309,013
-90,571
-23% -$5.84M 0.15% 145
2020
Q4 		$23.3M Buy
399,584
+29,220
+8% +$1.76M 0.16% 142
2020
Q3 		$23.4M Sell
370,364
-58,894
-14% -$4.08M 0.16% 137
2020
Q2 		$33M Buy
429,258
+108,033
+34% +$8.28M 0.26% 74
2020
Q1 		$24M Sell
321,225
-239,325
-43% -$16.5M 0.22% 105
2019
Q4 		$36.4M Sell
560,550
-888
-0.2% -$57.8K 0.25% 92
2019
Q3 		$35.6M Sell
561,438
-7,446
-1% -$487K 0.22% 108
2019
Q2 		$38.4M Sell
568,884
-113,015
-17% -$7.43M 0.26% 82
2019
Q1 		$44.3M Buy
681,899
+32,248
+5% +$2.14M 0.32% 61
2018
Q4 		$40.6M Sell
649,651
-203,393
-24% -$14.2M 0.33% 55
2018
Q3 		$65.9M Buy
853,044
+113,752
+15% +$8.59M 0.5% 26
2018
Q2 		$52.4M Buy
739,292
+10,336
+1% +$730K 0.36% 46
2018
Q1 		$55M Buy
+728,956
New +$57.9M 0.34% 49

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackay Shields LLC's GILD Position: Q2 2022 in Review

Mackay Shields LLC sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 181,555 shares — an estimated $10.8M sold.

Mackay Shields LLC first reported a position in GILD in Q1 2018 and held it in 17 quarters. The position peaked at $65.9M in Q3 2018. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Mackay Shields LLC reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 181,555 Gilead Sciences shares in Q2 2022, an estimated $10.8M.
  • Mackay Shields LLC first reported a position in Gilead Sciences in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Gilead Sciences position peaked at $65.9M in Q3 2018.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.